← Back to Search

PREVENT Program for Hip Fractures

N/A
Recruiting
Led By Alexandra Papaioannou, MD, MSc
Research Sponsored by McMaster University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one year
Awards & highlights
No Placebo-Only Group

Summary

This trial is studying a program called PREVENT that was designed to prevent hip fractures in older adults living in long-term care homes. Hip fractures are common in this population and can lead to hospitalization,

Who is the study for?
The PREVENT trial is for older adults in long-term care homes in Ontario and Alberta who are at risk of hip fractures due to osteoporosis and falls. Homes must have at least 70 residents to join. The study will use health records to identify eligible participants.
What is being tested?
This trial tests the PREVENT program, which uses a fracture risk calculator and trains healthcare teams on fracture prevention strategies. It compares homes using this program with those that provide usual care to see if it reduces hip fractures.
What are the potential side effects?
Since the intervention involves educational tools and processes rather than medications, there are no direct side effects like you'd expect from drugs. However, changes in care plans could indirectly affect resident well-being.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one year
This trial's timeline: 3 weeks for screening, Varies for treatment, and one year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of hip-fractures
Secondary study objectives
Change in health related quality of life
Change in level of pain
Change in medications and supplements
+6 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: PREVENT ProgramExperimental Treatment1 Intervention
Group II: Control GroupActive Control1 Intervention
Residents in homes allocated to the control group will receive usual care as provided within their home.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
PREVENT Program
2022
N/A
~40

Find a Location

Who is running the clinical trial?

McMaster UniversityLead Sponsor
918 Previous Clinical Trials
2,613,233 Total Patients Enrolled
6 Trials studying Osteoporosis
7,190 Patients Enrolled for Osteoporosis
Alexandra Papaioannou, MD, MScPrincipal InvestigatorMcMaster University
7 Previous Clinical Trials
7,326 Total Patients Enrolled
2 Trials studying Osteoporosis
6,840 Patients Enrolled for Osteoporosis
~680 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top